Finance

Lists
TORNTPHARM:NSE
Torrent Pharmaceuticals Ltd
4 772,50 ₹
-0,57%
(-27,50) 1D
1 қаз., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for TORNTPHARM...
Open
4 800,00 ₹
High
4 810,50 ₹
Low
4 717,30 ₹
Mkt. cap
1,61 трлн
Avg. vol.
331,85 м.
Volume
357,70 м.
Dividend
0,80%
Quarterly dividend
9,50 ₹
Ex-dividend date
2026 ж. 29 мам.
P/E ratio
76,24
52-wk high
5 250,00 ₹
52-wk low
3 480,60 ₹
EPS
62,60 ₹
Shares outstanding
170,00 млн
No. of employees
18 мың
Open
4 800,00 ₹
High
4 810,50 ₹
Low
4 717,30 ₹
Mkt. cap
1,61 трлн
Avg. vol.
331,85 м.
Volume
357,70 м.
Dividend
0,80%
Quarterly dividend
9,50 ₹
Ex-dividend date
2026 ж. 29 мам.
P/E ratio
76,24
52-wk high
5 250,00 ₹
52-wk low
3 480,60 ₹
EPS
62,60 ₹
Shares outstanding
170,00 млн
No. of employees
18 мың
News stories
From web sources and news partners
Profile
Torrent Pharmaceuticals Ltd, d/b/a Torrent Pharma, is an Indian multinational pharmaceutical company, part of the Torrent Group and headquartered in Ahmedabad. It was promoted by U. N. Mehta, initially as Trinity Laboratories Ltd, and was later renamed Torrent Pharmaceuticals Ltd. Torrent Pharmaceuticals operates in more than 40 countries with over 2,000 product registrations globally. Torrent Pharma is active in the therapeutic areas of cardiovascular, central nervous system, gastro-intestinal, diabetology, anti-infective and pain management segments. It also has a presence in therapeutic segments of nephrology, oncology, gynecology, respiratory and pediatrics. Wikipedia
About Torrent Pharmaceuticals Ltd
CEO-
Employees18,3 мың
Founded1959
HeadquartersАхмадабад, Гуджарат, Үндістан
SectorPharmaceutical industry
Last report
2026 ж. 30 шіл.
Fiscal period
Q1 2027
EPS / Est. (INR)
15,30 ₹ / 16,20 ₹
-5,55%miss
Revenue / Est. (INR)
49,21 млрд / 47,29 млрд
+4,07%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
33,02 млрд
33,03 млрд
41,97 млрд
49,21 млрд
Cost of goods sold
8,00 млрд
7,99 млрд
10,15 млрд
11,63 млрд
Cost of revenue
8,00 млрд
7,99 млрд
10,15 млрд
11,63 млрд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6,27 млрд
6,51 млрд
8,48 млрд
8,93 млрд
Operating expense
16,23 млрд
16,22 млрд
23,34 млрд
26,87 млрд
Total operating expenses
24,23 млрд
24,21 млрд
33,49 млрд
38,50 млрд
Operating income
8,79 млрд
8,82 млрд
8,48 млрд
10,71 млрд
Other non operating income
-270,00 млн
-130,00 млн
794,40 млн
-120,00 млн
EBT including unusual items
7,91 млрд
8,14 млрд
5,29 млрд
7,33 млрд
EBT excluding unusual items
8,04 млрд
8,24 млрд
5,47 млрд
7,54 млрд
Income tax expense
2,00 млрд
1,79 млрд
1,65 млрд
1,67 млрд
Effective tax rate
25,28%
21,99%
31,18%
22,78%
Other operating expenses
7,92 млрд
7,65 млрд
9,78 млрд
12,01 млрд
Net income
5,91 млрд
6,35 млрд
3,89 млрд
5,66 млрд
Net profit margin
17,90%
19,22%
9,28%
11,50%
Earnings per share
17,75
19,00
12,85
15,30
Interest and investment income
-
-
384,30 млн
-
Interest expense
-480,00 млн
-450,00 млн
-2,36 млрд
-3,05 млрд
Net interest expenses
-480,00 млн
-450,00 млн
-1,97 млрд
-3,05 млрд
Depreciation and amortization charges
2,04 млрд
2,06 млрд
5,08 млрд
5,93 млрд
EBITDA
10,82 млрд
10,69 млрд
11,12 млрд
13,35 млрд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары